The patch provided stable glycemic control for approximately 8 h and effectively responded to glycemic challenges, critically avoiding the sharp hypoglycemic nadir and subsequent rebound hyperglycemia associated with conventional subcutaneous insulin injections. Here, INS is linked to Hyperglycemia.